Tiziana Life Sciences Ltd (TLSA) concluded trading on Thursday at a closing price of $1.50, with 4.52 million shares of worth about $6.78 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 59.56% during that period and on March 06, 2025 the price saw a gain of about 10.29%. Currently the company’s common shares owned by public are about 102.27M shares, out of which, 71.76M shares are available for trading.
Stock saw a price change of 32.74% in past 5 days and over the past one month there was a price change of 121.96%. Year-to-date (YTD), TLSA shares are showing a performance of 115.46% which increased to 219.22% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.41 but also hit the highest price of $1.74 during that period. The average intraday trading volume for Tiziana Life Sciences Ltd shares is 858.52K. The stock is currently trading 58.48% above its 20-day simple moving average (SMA20), while that difference is up 83.70% for SMA50 and it goes to 61.96% higher than SMA200.
Tiziana Life Sciences Ltd (NASDAQ: TLSA) currently have 102.27M outstanding shares and institutions hold larger chunk of about 0.91% of that.
The stock has a current market capitalization of $165.99M and its 3Y-monthly beta is at 0.43. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for TLSA, volatility over the week remained 25.88% while standing at 14.11% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by B. Riley Securities on December 22, 2020 offering a Buy rating for the stock and assigned a target price of $8 to it.
